Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30355453

Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2018 Nov
First author
Shitara K

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 Nov;19(11):1418-1419. doi: 10.1016/S1470-2045(18)30752-6.
    note
    Source null
    related pmid
    30355454
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2018 Dec;19(12):e668. doi: 10.1016/S1470-2045(18)30843-X.
    note
    Source null
    related pmid
    30507432
    relationship
    Erratum in
  3. citation
    Lancet Oncol. 2019 Jan;20(1):e8. doi: 10.1016/S1470-2045(18)30908-2.
    note
    Source null
    related pmid
    30614483
    relationship
    Comment in

Authors and identifiers

  1. name
    Shitara K
    type
    Author
  2. name
    Doi T
    type
    Author
  3. name
    Dvorkin M
    type
    Author
  4. name
    Mansoor W
    type
    Author
  5. name
    Arkenau HT
    type
    Author
  6. name
    Prokharau A
    type
    Author
  7. name
    Alsina M
    type
    Author
  8. name
    Ghidini M
    type
    Author
  9. name
    Faustino C
    type
    Author
  10. name
    Gorbunova V
    type
    Author
  11. name
    Zhavrid E
    type
    Author
  12. name
    Nishikawa K
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Shitara K
    type
    Author
  2. name
    Doi T
    type
    Author
  3. name
    Dvorkin M
    type
    Author
  4. name
    Mansoor W
    type
    Author
  5. name
    Arkenau HT
    type
    Author
  6. name
    Prokharau A
    type
    Author
  7. name
    Alsina M
    type
    Author
  8. name
    Ghidini M
    type
    Author
  9. name
    Faustino C
    type
    Author
  10. name
    Gorbunova V
    type
    Author
  11. name
    Zhavrid E
    type
    Author
  12. name
    Nishikawa K
    type
    Author
bibliography ids
  1. nci-bib-a60c872bba15cb237d95c043
book metadata
content sha256
514f4a8bdcda50235534f00435bfe22b9a46cb25e0ae888584738ce59a28ecf4
document type
citation
dois
  1. 10.1016/S1470-2045(18)30739-3
electronic publication date
display
2018 Oct 21
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:30355453
immutable id
pubmed:30355453@514f4a8bdcda50235534f00435bfe22b9a46cb25e0ae888584738ce59a28ecf4
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
11
name
The Lancet. Oncology
nlm unique id
100957246
pages
1437-1448
volume
19
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 Nov;19(11):1418-1419. doi: 10.1016/S1470-2045(18)30752-6.
    note
    Source null
    related pmid
    30355454
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2018 Dec;19(12):e668. doi: 10.1016/S1470-2045(18)30843-X.
    note
    Source null
    related pmid
    30507432
    relationship
    Erratum in
  3. citation
    Lancet Oncol. 2019 Jan;20(1):e8. doi: 10.1016/S1470-2045(18)30908-2.
    note
    Source null
    related pmid
    30614483
    relationship
    Comment in
outcomes validated
false
pmid
30355453
provenance
batch id
438b2803888025c6cf56
provider
NCBI PubMed ESummary
record sha256
d7236196a63e74c4dcf287c3f5fb7498221a8912ee81f225f0f813c7a5413b6c
response sha256
0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
retrieved at
2026-09-09T23:47:36.359220+00:00
publication date
display
2018 Nov
precision
month
year
2018
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30355453/
title
Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial.

Preserved source evidence · Not medical advice